A Decade of War Pushes PTSD To the Forefront in Healthcare Concerns

As the US begins to see more and more soldiers return home from combat after the last decade of wars, finding a viable treatment for PTSD should and will be a more prominent concern in the minds of many.

Read more »

PTSD Special Report: Part I, How to Curb a Potential Epidemic

In response to a recent press release from TONIX Pharmaceuticals, a leading company in the exploration of alternative PTSD treatment, we are issuing a 2-part special report looking at recent developments

Read more »

TONIX Pharmaceuticals Completes $4.3 Million Private Placement Funding

The company received net proceeds of approximately $1.9 million in the offering and converted an additional $1.9 million in previously convertible debentures as part of the offering.

Read more »

Fibromyalgia Treatment Re-Engineered to Reach Unmet Medical Conditions

TONIX Pharmaceuticals announced the publication of data in the peer-reviewed journal, The Journal of Rheumatology, demonstrating an improvement in core symptoms associated with FM.

Read more »